title: Roundtable III: Impact of rheumatoid arthritis on the healthcare industry.
authors.forename: S
authors.initials: S
authors.lastname: Berney
authors.forename: L
authors.initials: L
authors.lastname: Ding
authors.forename: M
authors.initials: M
authors.lastname: Fornataro
authors.forename: R
authors.initials: R
authors.lastname: Hailey
authors.forename: R
authors.initials: R
authors.lastname: Jarrett
authors.forename: M
authors.initials: M
authors.lastname: Kaufman
authors.forename: E
authors.initials: E
authors.lastname: Komrad
authors.forename: P
authors.initials: P
authors.lastname: Penna
authors.forename: B
authors.initials: B
authors.lastname: Triebel
mesh_terms: D001172:Arthritis, Rheumatoid / Q000191:economics* / Q000473:pathology / Q000628:therapy; D003657:Decision Making; D019468:Disease Management; D005569:Formularies as Topic; D019981:Health Care Sector; D006297:Health Services Accessibility; D006801:Humans; D008329:Managed Care Programs / Q000191:economics*; D017063:Outcome Assessment, Health Care; D018579:Patient Selection; D008486:Physician Executives; D017410:Practice Guidelines as Topic; D012720:Severity of Illness Index; D014481:United States